Dr. Yasser Kandil, Currently, he works as an associate professor of biochemistry and clinical biochemistry. Yasser has held several leadership roles in the Faculty of Pharmacy, supervised many M.Sc. and Ph.D. dissertations, and served as a reviewer of several international reputed journals.
Yasser has several publications related to the ameliorative effects of natural antioxidants against the cytotoxicity of anticancer drugs in vitro and in vivo: primarily to improve their efficacy in tumour cells while minimizing the associated toxicities to non-cancerous tissues.
His research interests include but are not limited to the following; Molecular biology, Cancer cell biology, Oxidative stress, Diabetes Mellitus, and Clinical nutrition. Utilizing molecular techniques, PCR, immunoblotting, ELISA, electrophoresis, cell culturing, applied Biostatistics, and several serological analyses.
Yasser is currently participating in common projects studying some cellular and molecular targets to increase the chemosensitivity of cancer cells to the chemotherapeutic treatment. He is willing to collaborate in research projects with other research and focus groups.
Dr. Yasser Kandil, Currently, he works as an associate professor of biochemistry and clinical biochemistry. Yasser has held several leadership roles in the Faculty of Pharmacy, supervised many M.Sc. and Ph.D. dissertations, and served as a reviewer of several international reputed journals.
Yasser has several publications related to the ameliorative effects of natural antioxidants against the cytotoxicity of anticancer drugs in vitro and in vivo: primarily to improve their efficacy in tumour cells while minimizing the associated toxicities to non-cancerous tissues.
His research interests include but are not limited to the following; Molecular biology, Cancer cell biology, Oxidative stress, Diabetes Mellitus, and Clinical nutrition. Utilizing molecular techniques, PCR, immunoblotting, ELISA, electrophoresis, cell culturing, applied Biostatistics, and several serological analyses.
Yasser is currently participating in common projects studying some cellular and molecular targets to increase the chemosensitivity of cancer cells to the chemotherapeutic treatment. He is willing to collaborate in research projects with other research and focus groups.